Alberta employer dodges an estimated $120,000 in specialty drug costs

An Alberta employer that joined Quikcard in January 2026 avoided an estimated $120,000 in drug claims after coverage navigation redirected 12 specialty drug claims to other funding sources. The case underscores how high-cost medications are reshaping employer drug plans across Canada.

Why it matters: - Specialty drugs now account for a disproportionate share of employer drug spending, even though they are used by a small share of claimants. - A single high-cost claim can raise premiums at renewal for small and mid-sized employers. - Programs that shift specialty drug coverage to other funding sources can reduce pressure on group benefits budgets.

What happened: - An Alberta employer with 205 employees joined Quikcard’s benefits administration in January 2026. - Within months, Quikcard and ClaimSecure’s Formulary Protect Coverage Navigation team found alternative funding for 12 specialty drug claims in that group. - Quikcard estimated the avoided cost at about $120,000, based on the $10,000 minimum annual cost threshold for specialty drugs.

The details: - Specialty drugs are defined in the release as medications costing more than $10,000 a year. - TELUS Health’s 2026 Drug Data Trends and National Benchmarks Report says specialty drugs are used by 2.1% of private drug plan claimants but account for 33.9% of total eligible drug spending. - The number of Canadian drugs costing more than $10,000 a year rose from about 125 in 2005 to more than 960 by 2025. - Some treatments now cost up to $2.4 million. - For small and mid-sized employers, the usual response to a specialty drug claim is to absorb the increase, switch carriers or add a drug cap that affects all employees. - Formulary Protect removes drugs costing more than $10,000 a year from a plan’s standard drug list. - The navigation team helps employees pursue funding through provincial drug programs, manufacturer patient assistance programs, a spouse’s plan or a combination of sources. - The team also handles paperwork and coordinates with the employee’s physician and pharmacy. - Since launching in 2016, the program has found alternative funding in about 95% of cases nationally. - Because specialty drugs make up roughly 1% of prescriptions, the release says the chance of a claim going unfunded works out to about 5 in every 10,000 prescriptions across a plan.

Between the lines: - The case shows how specialty drug management is shifting from pure reimbursement toward active funding navigation. - The savings estimate is conservative because it uses the $10,000 minimum threshold, not the actual cost of each drug. - The model protects employer plans without forcing broad coverage cuts on employees who do not use specialty drugs. - ClaimSecure and Quikcard are positioning experience and province-by-province navigation as the core advantage, not just plan design.

What's next: - Quikcard HSA has published a guide for employers on who pays for high-cost drugs, what happens when funding cannot be found and what options are available at renewal. - The guide, including video from the Alberta case, is available here. - Formulary Protect is available to employers across Canada except Quebec. - Quikcard and ClaimSecure are likely to continue promoting the program as specialty drug spending grows.